Published in Healthcare Finance, Tax and Law Weekly, January 10th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Avanir Pharmaceuticals.
Report 1: Avanir Pharmaceuticals (AVNR) announced that it has received an approvable letter from the U.S. Food and Drug Administration (FDA) for Zenvia (formerly referred to as Neurodex) for the treatment of involuntary emotional expression disorder (IEED).
The company submitted a new drug application (NDA) in January 2006, seeking to market Zenvia for the treatment of IEED in patients with neurologic diseases and brain injuries. The communication from...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.